机译：缬更昔洛韦用于抢先治疗造血干细胞移植后巨细胞病毒性病毒血症的前瞻性多中心试验
^pof;
Hematology,;
Peking;
University;
People＇s;
Hospital,Beijing;
100044,;
China;
^pof;
Hematology,;
Peking;
University;
People＇s;
Hospital,Beijing;
100044,;
China;
^pDiseases;
Hospital,;
Chinese;
Academy;
of;
Medical;
Sciences;
and;
Peking;
Union;
Medical;
College,;
Tianjin;
300020,;
China;
^pHospital;
Affiliated;
to;
Zhejiang;
University,;
Hangzhou,Zhejiang;
310003,;
China;
^pHospital;
of;
People＇s;
Liberation;
Army,;
Beijing;
100071,;
China;
^pHospital,;
Nanfang;
Medical;
University,;
Guangzhou,Guangdong;
510515,;
China;
^pHospital;
Affiliated;
to;
Second;
Military;
Medical;
University;
of;
People＇s;
Liberation;
Army,;
Shanghai;
200433,;
China;
^pChina;
Hospital,;
Sichuan;
University,;
Chengdu,;
Sichuan;
610041,;
China;
^pTumor;
Hospital,;
Zhengzhou,;
Henan;
450008,;
China;
^pInstitute;
of;
Hematology;
＆;
Oncology,;
Harbin,;
Heilongjiang;
150010,;
China;
^pAffiliated;
Hospital;
of;
Soochow;
University,;
Suzhou,;
Jiangsu;
215006,;
China;
^pof;
Hematology,;
Union;
Hospital,;
Tongji;
Medic;
异基因造血干细胞移植; 人巨细胞病毒; 移植治疗; 病毒血症; 试验数据; 多中心; 发制; 病毒DNA;
